Parents flock to defend therapy centre shut down by Essex County Council
The council stopped referring children from across Essex, including Southend, to the Peaceful Pony Therapy and Alternative Education Centre in Stock Lane Billericay in February.
The equine centre, which offers vital care to children, teens and adults with a range of learning and neurodivergent conditions, struggled on until last week when it was forced to close for good.
Essex County Council has cited 'safeguarding issues' but has failed to outline what these were both to the owner Holly Lockewood-Waduge, a mental health nurse, who founded the not-for-profit centre more than four years ago, or to parents.
Vickie Pearce from Chelmsford used the centre for her 14-year-old daughter, Amber who has autistic, has cystic fibrosis and severe OCD. She said: 'Peaceful Pony have been the only provision that have met her needs and who have helped her grow educationally, emotionally.
'It doesn't make any sense. We've had no clear answers or discussion about it. They're very, very supportive of children who are autistic and most compassionate understanding.
'There is no other provision that matches them or could replace them in the whole of Essex.'
Following the closure Essex County Council said it had made other provision for the children but this has been hotly contested by parents.
Sarah Matthew, from Basildon whose daughter, Lily, 15, attended the centre, said: 'I'm furious. There isn't any other provider that's approved on their list that is anything like the Peaceful Pony.
'Staff had taken the time for Lily to really slowly get to know them and do things at her pace. There is one place that is a tiny bit similar but that's in Colchester and my daughter would just not cope with the drive every day.'
Lisa Brightmore, from Braintree took her daughter Eloise, 14, to the centre. She said: 'It's very sad and unfortunately, it's been dealt with incredibly poorly. I don't understand the safeguards that were involved so I wrote a letter to the council asking them to explain to me the due diligence that they've done. They refused to answer.'
Ms Lockwood-Waduge, who is taking legal action against the council, said: 'I'm just gobsmacked.
'They've never been able to provide any evidence and then they say that all of the children have been moved onto other to put other provisions. They absolutely haven't.'
A spokesperson for Essex County Council said: 'We would like to reiterate that the decisions made surrounding the withdrawal from the Peaceful Pony provision were made following extensive consultation with the Peaceful Pony team. We do not make such decisions lightly.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
Phone notes made by trans doctor after nurse dispute were edited, tribunal told
Phone notes made by a transgender doctor following a dispute with a nurse had been edited, a tribunal has heard. An employment tribunal was told on Friday that NHS Fife did not commission a forensic or in-person examination of Dr Beth Upton's phone in May 2025. The health board's security analyst 'did not have a technical answer' for discrepancies on dates on Google Notes made by Dr Upton, the tribunal heard. Sandie Peggie was suspended after she complained about having to share a changing room with Dr Upton at Victoria Hospital in Kirkcaldy, Fife, on Christmas Eve 2023. The nurse was placed on special leave after Dr Upton made an allegation of bullying and harassment and cited concerns about 'patient care'. Ms Peggie has lodged a claim against NHS Fife and Dr Upton, citing the Equality Act 2010, including sexual harassment; harassment related to a protected belief; indirect discrimination; and victimisation. The tribunal heard entries on Google Notes had 'discrepancies' between the date of editing and date of creation. Independent IT expert Jim Borwick, director of KJB Computer Forensics Consultancy, was commissioned by Ms Peggie's representatives and agreed he was suggesting the doctor 'was trying to mislead' the tribunal. In a report, Mr Borwick wrote 'Dr Upton is silent on fact that Notes can be rearranged with relative ease', and that he was 'perplexed' and 'at a loss' as to how the discrepancies had occurred, and was told 'notes did not include patient care allegations Dr Upton made about Ms Peggie', the tribunal heard. One note from December 18, 2023 logged 'working nights, won't make eye contact, won't acknowledge my presence, haven't had direct conversation but can feel the dismissal/hostility', which was edited on December 26 at 1.21am, the tribunal heard. Mr Borwick said: 'In addition to text on that date, this had been added so it is not contemporaneous.' He confirmed he was 'suggesting that Dr Upton is trying to mislead the tribunal', when asked by Jane Russell KC, representing NHS Fife and Dr Upton. Ms Russell said: 'When you said Dr Upton is silent on fact that notes can be rearranged, you're suggesting that Dr Upton is trying to mislead the tribunal?' The IT expert said: 'I suppose that's my comment, yes.' Ms Russell asked if he had been instructed 'to come up with explanation that there were lies on the part of Dr Upton' and to 'undermine Dr Upton's account of patient care allegations'? The witness said: 'I don't think we were trying to undermine anything, it was just a case of trying to look at these notes.' He added: 'I was told to recover notes about patient care allegations; no reason was given, just to recover those notes.' He suggested a Teams meeting should have been recorded, and that screenshots could have been 'superimposed' on notes. Ms Russell said in one screenshot 'the conundrum is that the edited date predates the created date', and asked if 'the only explanation for discrepancy is that Dr Upton is lying about creation dates'. The witness said: 'I can't recreate this, Mr Donaldson [Peter Donaldson, information security manager for NHS Fife] can't; this can't happen. It just can't happen that way.' However, Ms Peggie's junior counsel, Charlotte Elves, said she was 'astonished' at a suggestion that anyone 'would have instructed an expert to lie, or that an expert would accept such instructions'. The tribunal heard a note titled 'weird incident 26.08.23' was timestamped showing it was created on October 26, 2023, according to Google. The tribunal also heard evidence that Dr Upton was remotely supervised at one point during a Teams call by Mr Donaldson. Giving evidence, Mr Donaldson said: 'I don't believe Dr Upton was trying to mislead us in any way. 'I completely agree this is how Google presents; on the face of it the October date is the earliest date. I don't dispute that. The notes supplementary to that are the same.' Ms Elves said: 'This quandary that we've got about creation on October 26, as I understand it, there's no understandable technical explanation?' Mr Donaldson said: 'Not that I'm aware of.' Ms Elves said: 'You say you don't believe Dr Upton was trying to mislead the tribunal but presumably accept that is one explanation for this inexplicable phenomenon?' The witness said: 'It is a possibility but I don't believe that's the case.' Ms Elves said: 'Going back to apparent difficulty with the screenshots, I think you told the tribunal that you can't fathom any technological explanation; do you accept that one explanation for images that purport to show the inexplicable is they have been manipulated?' Mr Donaldson said: 'I can't say it's impossible.' The tribunal continues.


Medscape
29 minutes ago
- Medscape
EMA Launches Review of Tecovirimat Effectiveness for Mpox
The European Medicines Agency (EMA) has initiated a review of Tecovirimat SIGA, also called TPOXX, a medicine used to treat mpox. This follows emerging clinical trial data suggesting a lack of effectiveness. The mpox virus is an orthopoxvirus, a class that includes the smallpox virus. Tecovirimat SIGA was originally approved in the US to treat smallpox. The EMA and the Medicines and Healthcare products Regulatory Agency in the UK authorized its use in January 2022, at the start of an mpox outbreak in Europe, for the treatment of smallpox, mpox, cowpox, and vaccinia complications following smallpox vaccination, in adults and children weighing at least 13 kg. The drug is an oral medicine that interferes with a protein called VP37 found on the surface of orthopoxviruses, preventing them from reproducing normally and thus slowing the spread of infection. No other treatments are authorized for mpox or cowpox infections, which may in rare cases be fatal. European Cases Linked With Risky Sexual Behaviors Mpox is a zoonotic infection occurring mainly in West and Central Africa, with most cases in Europe before 2022 either imported from countries where mpox is endemic or from contacts with documented epidemiological links to imported cases. The outbreak in the EU and UK has been transmitted between humans mainly through sexual contact. It primarily affects gay, bisexual, or other men who have sex with men and who have multiple sexual partners, participate in group sex, or attend sex-on-premises venues. Transmission occurs primarily within interconnected sexual networks. Symptoms of mpox typically appear 1-3 weeks after infection and include fever, headache, chills, physical weakness, lymph node swelling, back pain, and muscle aches, along with a distinct, fast-spreading papular rash on the skin and mucosal sores in the mouth, nose, throat, or digestive tract that then turn into fluid-filled vesicles. Mild-to-moderate symptoms usually last 2-4 weeks and are followed by full recovery, though some people develop permanent scars. During outbreaks, the case fatality of mpox ranges from 0% to 11%. People who are immunocompromised, including those with HIV infection or AIDS, are at a higher risk for severe disease. Exceptional Circumstances Approval During Outbreak Approval for Tecovirimat SIGA was granted under 'exceptional circumstances' provisions, based only on pharmacodynamic and pharmacokinetic studies, because the disease is rare and sporadic, so human studies were not available. A condition of such authorization is that the company marketing Tecovirimat SIGA is required to provide an annual update on benefits and risks. The EMA's review is a postauthorization procedure that involves a scientific assessment by the agency on behalf of the EU aimed at resolving issues such as concerns over the safety or benefit-risk balance of a medicine or a class of medicines. In the case of Tecovirimat SIGA (tecovirimat), the review was initiated at the request of the European Commission. The review follows publication of preliminary results from two clinical trials. In the randomized, placebo-controlled PALM007 trial involving 597 children and adults with laboratory-confirmed clade I mpox in the Democratic Republic of the Congo (DRC), results reported in April in The New England Journal of Medicine showed that the drug did not reduce the duration of mpox lesions (median time to resolution, 7 vs 8 days). The overall mortality among enrollees, regardless of whether or not they received the drug, was 1.6% — much lower than that generally reported in the DRC, but this was attributed to hospitalization and high-quality supportive care within the trial. The other trial, STOMP, involved people from multiple countries with mild-to-moderate laboratory-confirmed or presumptive clade II mpox. Again, the active drug did not demonstrate efficacy in time to skin and mucosal lesion resolution compared with placebo. The EMA said that similar results had recently been obtained from another study, UNITY, which also did not indicate faster skin lesion resolution on tecovirimat compared with placebo. Further analyses from ongoing or recently completed studies are still awaited and will also inform the EMA's final assessment.
Yahoo
an hour ago
- Yahoo
There were 'failings' in care of ex-England cricketer Graham Thorpe in months before he died, coroner says
There were "failings" in the care of former England cricketer Graham Thorpe in the months before he died, a coroner has said. It comes as Coroner Jonathan Stevens recorded a conclusion of suicide at an inquest into his death in August last year. Thorpe died at a railway station in Surrey after being struck by a train. Mr Stevens read a statement yesterday during the inquest from Thorpe's GP, Joan Munnelly, detailing the cricketer was diagnosed with anxiety and depression in 2018. Speaking on Friday, the coroner said that the last time Thorpe was seen in person by healthcare professionals was on 20 March 2024. "In my judgment there were shortcomings in the care that should have been provided to Graham in the last four months or so of his life," he told the court. Mr Stevens then added that "there were failings in the provision of his care," but said he cannot, on the evidence, conclude that the failures were gross - and so he cannot conclude that Thorpe would not have died if it were not for the failures. "It's clear there were shortcomings in his care," he continued. "If he had been seen in those last four months, particularly after that incident on 28 June, I cannot say whether it would or would not have made any difference." Regarded as one of the finest batters of his generation, Thorpe played 100 Tests for England, scoring 16 centuries and featuring 82 times for the ODI side. He coached England's batters and had a 17-year career with Surrey. Anyone feeling emotionally distressed or suicidal can call Samaritans for help on 116 123 or email jo@ in the UK. In the US, call the Samaritans branch in your area or 1 (800) 273-TALK This breaking news story is being updated and more details will be published shortly. Please refresh the page for the latest version. You can receive breaking news alerts on a smartphone or tablet via the Sky News app. You can also follow us on WhatsApp and subscribe to our YouTube channel to keep up with the latest news.